BNP Paribas Health Cr Innovtr Cl Cap

-3.60%
hittil i år

Sammenlign

Dette fondet

Tidsserie

Konsentrasjon

🌶🌶🌶

Type

Bransjefond

Bærekraft

🌳🌳🌳

Beskrivelse

This sub-fund increases the value of its assets over the medium term by investing in healthcare innovative companies. At all times, this sub-fund invests at least 75% of its assets in equities and/or equity equivalent securities issued worldwide by health care companies that enable or benefit from innovative technologies, including, but not limited to, advances in genetic sequencing, drug delivery, miniaturization, bio-compatible materials, haptics and information technology to the healthcare field. The remaining portion, namely a maximum of 25% of its assets, may be invested in any other transferable securities, money market instruments, or cash, provided that investments in debt securities of any kind do not exceed 15% of its assets, and up to 10% of its assets may be invested in UCITS or UCIs.

Avkastning

Siste 30 dager

1.32%

Siste 6 måneder

-1.76%

Hittil i år

-3.60%

Siste år

8.37%

Siste 3 år (Per år)

14.12%

Siste 5 år (Per år)

10.64%

Pris

Vis priser med rabatt for
 Akademikerne Pluss
Er du ikke medlem? Meld deg inn her

Pris for fondet

1.98%

Plattformavgift

0.25%

Returprovisjon

0.75%

Totalpris
(Det du betaler årlig)

1.48%

Nøkkelinformasjon

Risiko

6 av 7

Morningstar-rating

3 av 5

Gyldig for aksjesparekonto

Ja

Tilgjengelig for pensjon

Nei

Aksjer

98.26%

Kontanter

1.74%

Selskaper med størst posisjon

  • UNITEDHEALTH GROUP INC
    9.67%
  • ASTRAZENECA PLC
    6.79%
  • ELI LILLY
    6.54%
  • BRISTOL MYERS SQUIBB
    6.09%
  • ROCHE HOLDING PAR AG
    4.46%
  • BOSTON SCIENTIFIC CORP
    3.95%
  • JAZZ PHARMACEUTICALS PLC
    3.94%
  • HORIZON THERAPEUTICS PUBLIC PLC
    3.39%
  • THERMO FISHER SCIENTIFIC INC
    3.38%
  • CENTENE CORP
    3.25%

Sektorer

  • Helse
    99.23%
  • Industri
    0.77%

Regioner

  • Nord-Amerika
    76.92%
  • Europa
    17.97%
  • Asia
    2.57%
  • Norden
    2.54%
  • Latin-Amerika
    0%
  • Afrika/Midt-Østen
    0%